Zhitong Finance App News, Fosun Pharmaceutical (600196.SH) announced that on September 23, 2026, the holding subsidiary Fuhong Hanlin signed a “Cooperation and License Agreement” with Amberstone. Fuhong Hanlin was granted an exclusive license by Amberstone to research, develop, produce and commercialize two cooperative products (i.e. T Cell Engager (TCE) products) for agreed targets globally and in all fields of human use based on the T-MATE™ technology platform.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.